In our study, immunofluorescence staining from stage II DKD samples show a slight activation of the C3 component (Figure 3); however, due to the limited number of human biopsies of early-DKD samples, we could not reach statistically significant results. This evidence concerns the gene C3 and diabetic kidney disease.